甘露醇市場規模、佔有率及成長分析（按形態、應用和地區分類）－2026-2033年產業預測

預計到 2024 年，全球甘露醇市場規模將達到 4.7969 億美元，到 2025 年將達到 5.0655 億美元，到 2033 年將達到 7.8331 億美元，在預測期（2026-2033 年）內複合年成長率為 5.6%。

由於人口結構和生活方式的改變，以及某些疾病的流行，全球甘露醇市場預計將持續成長。甘露醇在製藥業中被用作藥物製劑的添加劑，並應用於腎臟、腦部和心臟疾病的治療，以及作為片劑生產的填充劑，這些都凸顯了其重要性。甘露醇具有高水溶性、低塑性和低濕度敏感性等特性，使其成為製造商的首選原料。此外，消費者對無糖產品的需求不斷成長，尤其是在注重健康的消費者和糖尿病患者中，預計將進一步推動市場成長。利用乳酸菌進行合成製程的創新可望實現成本效益高且永續性的生產，為各種醫療應用帶來新的機遇，並持續提升市場潛力。

全球甘露醇市場促進因素

全球對甘露醇的需求主要受其作為活性藥物成分（API）在多種治療糖尿病、心臟病和癌症等慢性疾病的藥物中的應用影響。隨著這些疾病在全球發病率的持續上升，對有效治療方法的需求日益成長，甘露醇在製藥業的重要性也隨之提升。其在藥物製劑中的應用不僅凸顯了其治療價值，也強調了其對改善患者預後的顯著貢獻。因此，越來越多的患者尋求有效控制這些慢性疾病，推動了甘露醇市場的成長，也反映了其在現代醫學中的關鍵作用。

限制全球甘露醇市場的因素

全球甘露醇市場面臨來自各種低熱量甜味劑（例如甜菊糖、阿斯巴甜和蔗糖素）的激烈競爭。這些替代甜味劑的存在可能會降低甘露醇的吸引力，尤其是在食品飲料行業，導致需求下降。隨著消費者擴大轉向這些具有相似甜度和多種健康益處的替代品，這種競爭格局可能會阻礙製造商投資甘露醇生產。因此，消費者對其他甜味劑的持續偏好對甘露醇市場的成長和擴張構成了重大阻礙因素。

全球甘露醇市場趨勢

全球甘露醇市場需求顯著成長，主要促進因素是其作為製藥業關鍵輔料的作用，能夠提高藥物溶解度和生物利用度。隨著慢性病發病率的持續上升，製藥業不斷創新以開發更有效的治療方法，甘露醇的應用也日益廣泛。此外，對先進藥物遞送系統的日益關注以及對符合嚴格監管標準的高品質輔料的需求，進一步推動了這一趨勢。因此，在不斷成長的醫療需求和不斷發展的製藥應用的雙重驅動下，甘露醇市場正經歷強勁成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境

全球甘露醇市場規模（依形態及複合年成長率分類）（2026-2033 年）

• 粉末
• 顆粒狀

全球甘露醇市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 食品工業
• 製藥
• 工業的
• 界面活性劑
• 個人護理
• 其他

全球甘露醇市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Roquette Freres（France）
• Cargill, Incorporated（United States）
• Ingredion Incorporated（United States）
• SPI Pharma（United States）
• Shijiazhuang Huaxu Pharmaceutical Co., Ltd.（China）
• Qingdao Bright Moon Seaweed Group Co., Ltd.（China）
• Singsino Group Ltd.（China）
• Shandong Lianmeng International Trade Co., Ltd.（China）
• Merck KGaA（Germany）
• Pfizer Inc.（United States）
• DuPont de Nemours, Inc.（United States）
• Archer Daniels Midland Company（United States）
• Tate & Lyle PLC（United Kingdom）
• Mitsubishi Shoji Foodtech Co., Ltd.（Japan）
• Hebei Huaxu Pharmaceutical Co., Ltd.（China）
• Akhil Healthcare（India）
• Spectrum Chemical Manufacturing Corp.（United States）
• Caldic BV（Netherlands）
• Evonik Industries AG（Germany）
• Jungbunzlauer Suisse AG（Switzerland）

結論與建議

Global Mannitol Market size was valued at USD 479.69 Million in 2024 and is poised to grow from USD 506.55 Million in 2025 to USD 783.31 Million by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global mannitol market is poised for expansion, driven by demographic shifts, lifestyle changes, and the prevalence of certain medical conditions. Its applications in the pharmaceutical industry as an excipient for drug formulation and treatment of kidney, brain, and heart disorders, along with its use as a bulking agent in tableting, underscore its significance. Factors such as high water solubility, low moldability, and minimal humidity sensitivity make mannitol a preferred choice among manufacturers. Additionally, the rising demand for sugar-free products, especially among health-conscious consumers and diabetics, is expected to further propel market growth. Innovations in synthesis processes utilizing lactic acid bacteria promise cost-effective production and sustainability, offering new opportunities across various healthcare applications and enhancing market potential continuously.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mannitol market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mannitol Market Segments Analysis

Global Mannitol Market is segmented by Form, Application and region. Based on Form, the market is segmented into Powder and Granular. Based on Application, the market is segmented into Food Industry, Pharmaceuticals, Industrial, Surfactants, Personal Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mannitol Market

The global demand for mannitol is significantly influenced by its role as an active pharmaceutical ingredient (API) in various medications targeting chronic conditions, including diabetes, heart disease, and cancer. As the incidence of these diseases continues to rise across the globe, the need for effective treatments enhances the importance of mannitol in the pharmaceutical industry. Its utilization in drug formulations not only underscores its therapeutic value but also emphasizes its critical contribution to improving patient outcomes. Consequently, the expanding patient population seeking effective management of these chronic illnesses fuels the growth of the mannitol market, reflecting its essential role in modern healthcare.

Restraints in the Global Mannitol Market

The global mannitol market encounters significant challenges due to competition from various low-calorie sweeteners, including stevia, aspartame, and sucralose. The presence of these alternative sweetening agents can diminish the appeal of mannitol, leading to a potential decline in its demand, particularly within the food and beverage sector. This competitive landscape may deter manufacturers from investing in mannitol production, as consumers increasingly turn to these alternatives that offer similar sweetness profiles with varying health benefits. Consequently, the ongoing preference for other sweeteners poses a considerable restraint on the growth and expansion of the mannitol market.

Market Trends of the Global Mannitol Market

The Global Mannitol market is experiencing a pronounced surge in demand, primarily driven by its pivotal role in the pharmaceutical industry as a vital excipient that enhances drug solubility and bioavailability. As chronic diseases continue to rise and the pharmaceutical sector innovates to develop more effective therapeutic formulations, the utilization of mannitol is becoming increasingly prominent. This trend is further bolstered by the growing emphasis on advanced drug delivery systems and the need for high-quality excipients that meet stringent regulatory standards. Consequently, the market is witnessing robust growth, fueled by both rising healthcare needs and the evolution of pharmaceutical applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Mannitol Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Granular

Global Mannitol Market Size by Application & CAGR (2026-2033)

• Market Overview
• Food Industry
• Pharmaceuticals
• Industrial
• Surfactants
• Personal Care
• Others

Global Mannitol Market Size & CAGR (2026-2033)

• North America (Form, Application)
  • US
  • Canada
• Europe (Form, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Form, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Form, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Form, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ingredion Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shijiazhuang Huaxu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qingdao Bright Moon Seaweed Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singsino Group Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Lianmeng International Trade Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont de Nemours, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tate & Lyle PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Shoji Foodtech Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hebei Huaxu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akhil Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Chemical Manufacturing Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caldic B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jungbunzlauer Suisse AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations